Global Neuroprotective Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Neuroprotective Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Neuroprotective Drugs consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions.
Neuroprotective Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neuroprotective Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Alzheimer's disease and Parkinson's disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neuroprotective Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Neuroprotective Drugs key manufacturers include Genervon, NeuroVive Pharmaceutical, Ceregene, BHR Pharma, Neuren Pharmaceuticals, Allon therapeutics and Bionure, etc. Genervon, NeuroVive Pharmaceutical, Ceregene are top 3 players and held % sales share in total in 2022.
Neuroprotective Drugs can be divided into Cholinesterase inhibitors, Anti-inflammatory and Others,, etc. Cholinesterase inhibitors is the mainstream product in the market, accounting for % sales share globally in 2022.
Neuroprotective Drugs is widely used in various fields, such as Alzheimer's disease, Parkinson's disease and Others,, etc. Alzheimer's disease provides greatest supports to the Neuroprotective Drugs industry development. In 2022, global % sales of Neuroprotective Drugs went into Alzheimer's disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neuroprotective Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Genervon
NeuroVive Pharmaceutical
Ceregene
BHR Pharma
Neuren Pharmaceuticals
Allon therapeutics
Bionure
Segment by Type
Cholinesterase inhibitors
Anti-inflammatory
Others
Alzheimer's disease
Parkinson's disease
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Neuroprotective Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neuroprotective Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neuroprotective Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Neuroprotective Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neuroprotective Drugs introduction, etc. Neuroprotective Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Neuroprotective Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Neuroprotective Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neuroprotective Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Alzheimer's disease and Parkinson's disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neuroprotective Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Neuroprotective Drugs key manufacturers include Genervon, NeuroVive Pharmaceutical, Ceregene, BHR Pharma, Neuren Pharmaceuticals, Allon therapeutics and Bionure, etc. Genervon, NeuroVive Pharmaceutical, Ceregene are top 3 players and held % sales share in total in 2022.
Neuroprotective Drugs can be divided into Cholinesterase inhibitors, Anti-inflammatory and Others,, etc. Cholinesterase inhibitors is the mainstream product in the market, accounting for % sales share globally in 2022.
Neuroprotective Drugs is widely used in various fields, such as Alzheimer's disease, Parkinson's disease and Others,, etc. Alzheimer's disease provides greatest supports to the Neuroprotective Drugs industry development. In 2022, global % sales of Neuroprotective Drugs went into Alzheimer's disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neuroprotective Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Genervon
NeuroVive Pharmaceutical
Ceregene
BHR Pharma
Neuren Pharmaceuticals
Allon therapeutics
Bionure
Segment by Type
Cholinesterase inhibitors
Anti-inflammatory
Others
Segment by Application
Alzheimer's disease
Parkinson's disease
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Neuroprotective Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neuroprotective Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neuroprotective Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Neuroprotective Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neuroprotective Drugs introduction, etc. Neuroprotective Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Neuroprotective Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices